Bicocca Open Archive

Logo unimib boa
CHINELLO, CLIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.686
EU - Europa 7.132
AS - Asia 6.932
SA - Sud America 1.014
AF - Africa 106
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
Totale 27.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.350
SG - Singapore 2.690
IT - Italia 1.848
CN - Cina 1.696
DE - Germania 1.088
RU - Federazione Russa 940
HK - Hong Kong 922
VN - Vietnam 876
BR - Brasile 822
SE - Svezia 752
IE - Irlanda 731
GB - Regno Unito 396
AT - Austria 282
CA - Canada 250
UA - Ucraina 247
FR - Francia 186
IN - India 154
FI - Finlandia 145
ID - Indonesia 105
KR - Corea 97
NL - Olanda 96
PL - Polonia 90
DK - Danimarca 88
ES - Italia 79
AR - Argentina 72
JP - Giappone 58
MX - Messico 54
ZA - Sudafrica 54
BD - Bangladesh 53
TR - Turchia 53
BE - Belgio 45
EC - Ecuador 36
IQ - Iraq 30
IR - Iran 27
CZ - Repubblica Ceca 20
SA - Arabia Saudita 20
LT - Lituania 19
MA - Marocco 19
PK - Pakistan 19
UZ - Uzbekistan 18
CO - Colombia 17
AE - Emirati Arabi Uniti 15
AU - Australia 15
PE - Perù 15
VE - Venezuela 15
CH - Svizzera 14
IL - Israele 14
RO - Romania 14
TW - Taiwan 12
PY - Paraguay 11
UY - Uruguay 11
EU - Europa 10
PH - Filippine 9
AZ - Azerbaigian 8
CL - Cile 8
DO - Repubblica Dominicana 8
TH - Thailandia 8
BG - Bulgaria 7
BO - Bolivia 7
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 7
PA - Panama 7
DZ - Algeria 6
EG - Egitto 6
GR - Grecia 6
PT - Portogallo 6
AL - Albania 5
KE - Kenya 5
LV - Lettonia 5
NO - Norvegia 5
HR - Croazia 4
KG - Kirghizistan 4
NP - Nepal 4
BN - Brunei Darussalam 3
ET - Etiopia 3
HN - Honduras 3
LB - Libano 3
LU - Lussemburgo 3
SV - El Salvador 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
Totale 27.880
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.129
Singapore 1.585
Ashburn 1.366
Hong Kong 912
Milan 777
Fairfield 774
Chandler 722
Dublin 721
Frankfurt am Main 630
Woodbridge 626
Houston 536
Wilmington 532
Dallas 376
New York 372
Dearborn 358
Seattle 327
Santa Clara 316
Los Angeles 284
Ho Chi Minh City 268
Beijing 264
Vienna 247
Cambridge 244
Jacksonville 233
Hanoi 196
Hefei 191
Shanghai 181
Princeton 175
Nanjing 135
São Paulo 127
Buffalo 98
Chicago 91
Moscow 89
Munich 86
Seoul 81
The Dalles 70
Jakarta 69
Lawrence 63
Altamura 62
Fremont 59
Guangzhou 59
Kent 59
Nanchang 58
Helsinki 57
Warsaw 56
London 53
Council Bluffs 49
Toronto 49
Dong Ket 48
Denver 47
Brooklyn 46
Montreal 45
Orem 45
Nuremberg 44
Brussels 42
Lachine 40
San Diego 40
Stockholm 40
Tokyo 40
Ottawa 39
Montréal 38
Atlanta 35
Rome 33
Johannesburg 32
San Jose 32
Shenyang 32
Turku 31
Da Nang 29
Boston 28
Chennai 28
Phoenix 28
Amsterdam 27
Changsha 27
Lissone 27
Salt Lake City 27
Rio de Janeiro 26
San Francisco 26
Zhengzhou 26
Andover 25
Florence 25
Haiphong 25
Hải Dương 25
Poplar 24
Tianjin 24
Hebei 23
Düsseldorf 22
Manchester 21
Ha Long 20
Jinan 20
Pune 20
Caronno Pertusella 19
Falls Church 19
Kunming 19
Mexico City 19
Ningbo 19
Biên Hòa 18
Boardman 18
Columbus 18
Jiaxing 18
Norwalk 18
Belo Horizonte 17
Totale 18.336
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 543
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 498
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 484
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 468
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 466
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 464
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 415
Differential protein profiling of renal cell carcinoma urinary exosomes 408
Urinary exosomes and diabetic nephropathy: a proteomic approach 402
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 389
The putative role of MALDI-MSI in the study of Membranous Nephropathy 386
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 380
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 379
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 376
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 364
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 355
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 355
The proteomic landscape of renal tumors 348
Proteomics imaging and the kidney 336
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 330
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 323
Mutual Information Optimization for Mass Spectra Data Alignment 317
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 316
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 313
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 310
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 310
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 308
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 308
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 305
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 304
Robust conclusions in mass spectrometry analysis 303
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 302
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 300
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 295
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 295
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 294
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 280
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 277
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 275
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 272
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 271
Tumor size, stage and grade alterations of urinary peptidome in RCC 270
Proteome analysis in thyroid pathology 268
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 266
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 264
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 258
Analysis of correlation structures in renal cell carcinoma patient data 257
A molecular imaging approach to individuate tumour infiltrating lymphocytes 249
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 247
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 246
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 246
Imaging mass spectrometry: a new tool for kidney disease investigations 246
Intraluminal proteome and peptidome of human urinary extracellular vesicles 244
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 244
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 240
AQP1 expression analysis in human diseases: Implications for proteomic characterization 240
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 240
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 236
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 231
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 229
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 227
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 227
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 227
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 225
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 222
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 221
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 217
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 212
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 209
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 205
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 204
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 203
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 200
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 197
Poster: Characterization of distinguishing regions for renal cell carcinoma discrimination 196
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 196
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 196
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 194
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 193
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 193
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 192
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 191
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 185
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 184
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 177
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 171
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 170
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 169
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 167
Immunoreattività e carcinoma renale 164
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 159
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 156
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 154
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 153
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 147
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 146
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 146
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 143
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 143
Method for the in vitro diagnosis of thyroid diseases 141
Totale 26.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.438 0 0 0 0 0 0 329 292 205 224 154 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20255.434 222 473 345 220 481 215 318 222 558 943 587 850
2025/20267.966 1.940 753 1.169 1.689 1.665 717 33 0 0 0 0 0
Totale 28.756